Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
417M
-
Number of holders
-
121
-
Total 13F shares, excl. options
-
73.2M
-
Shares change
-
-16M
-
Total reported value, excl. options
-
$90M
-
Value change
-
-$14M
-
Put/Call ratio
-
0.71
-
Number of buys
-
47
-
Number of sells
-
-66
-
Price
-
$1.23
Significant Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q2 2024
163 filings reported holding CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock as of Q2 2024.
CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) has 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73.2M shares
of 417M outstanding shares and own 17.57% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (17.3M shares), RENAISSANCE TECHNOLOGIES LLC (11.3M shares), BlackRock Inc. (9.54M shares), PNC Financial Services Group, Inc. (5.01M shares), GEODE CAPITAL MANAGEMENT, LLC (3.96M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (2.85M shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (2.41M shares), Qube Research & Technologies Ltd (2.02M shares), CITADEL ADVISORS LLC (1.65M shares), and TWO SIGMA INVESTMENTS, LP (1.4M shares).
This table shows the top 121 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.